GILD |
Gilead Sciences, Inc. |
0 |
5.36% |
|
|
|
|
|
N/A |
0.00% |
29.57% |
37.05% |
---|
UTHR |
United Therapeutics Corporation |
0 |
5.03% |
|
|
|
|
|
N/A |
0.00% |
48.42% |
94.87% |
---|
NTRA |
Natera, Inc. |
0 |
5.02% |
|
|
|
|
|
N/A |
0.00% |
50.80% |
27.97% |
---|
BIIB |
Biogen Inc. |
0 |
4.91% |
|
|
|
|
|
N/A |
0.00% |
37.91% |
31.98% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
4.90% |
|
|
|
|
|
N/A |
0.00% |
44.19% |
59.43% |
---|
INCY |
Incyte Corporation |
0 |
4.85% |
|
|
|
|
|
N/A |
0.00% |
29.95% |
24.95% |
---|
ILMN |
Illumina, Inc. |
0 |
4.85% |
|
|
|
|
|
N/A |
0.00% |
43.77% |
32.05% |
---|
AMGN |
Amgen Inc. |
0 |
4.60% |
|
|
|
|
|
N/A |
0.00% |
24.21% |
15.61% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
0 |
3.08% |
|
|
|
|
|
N/A |
0.00% |
36.31% |
21.70% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
2.98% |
|
|
|
|
|
N/A |
0.00% |
62.93% |
38.49% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
2.98% |
|
|
|
|
|
N/A |
0.00% |
154.54% |
83.59% |
---|
EXAS |
Exact Sciences Corporation |
0 |
2.93% |
|
|
|
|
|
N/A |
0.00% |
61.38% |
69.18% |
---|
QGEN |
Qiagen N.V. |
0 |
2.92% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
5.06% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
0 |
2.89% |
|
|
|
|
|
N/A |
0.00% |
37.91% |
36.83% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
43.65% |
36.23% |
---|
MNKD |
MannKind Corporation |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
364.35% |
93.47% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
55.21% |
55.67% |
---|
HALO |
Halozyme Therapeutics, Inc. |
0 |
2.83% |
|
|
|
|
|
N/A |
0.00% |
37.99% |
27.06% |
---|
TECH |
Bio-Techne Corporation |
0 |
2.76% |
|
|
|
|
|
N/A |
0.00% |
53.97% |
69.22% |
---|
VCYT |
Veracyte, Inc. |
0 |
2.74% |
|
|
|
|
|
N/A |
0.00% |
85.97% |
38.91% |
---|
RPRX |
Royalty Pharma plc |
0 |
2.71% |
|
|
|
|
|
N/A |
0.00% |
29.01% |
24.62% |
---|
BPMC |
Blueprint Medicines Corporation |
0 |
2.68% |
|
|
|
|
|
N/A |
0.00% |
131.18% |
1.14% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
0 |
2.66% |
|
|
|
|
|
N/A |
0.00% |
88.88% |
43.23% |
---|
TGTX |
TG Therapeutics, Inc. |
0 |
2.64% |
|
|
|
|
|
N/A |
0.00% |
80.32% |
74.45% |
---|
XNCR |
Xencor, Inc. |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
576.42% |
26.57% |
---|
EXEL |
Exelixis, Inc. |
0 |
2.61% |
|
|
|
|
|
N/A |
0.00% |
40.13% |
36.86% |
---|
AXSM |
Axsome Therapeutics, Inc. |
0 |
2.50% |
|
|
|
|
|
N/A |
0.00% |
44.01% |
15.47% |
---|
CDNA |
CareDx, Inc |
0 |
2.46% |
|
|
|
|
|
N/A |
0.00% |
95.84% |
42.33% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
0 |
2.41% |
|
|
|
|
|
N/A |
0.00% |
78.56% |
17.07% |
---|
MYGN |
Myriad Genetics, Inc. |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
552.41% |
56.16% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
---|